Zydus LifeSciences enters into BTA for purchase from Watson Pharma
The Business Undertaking was catering to the API requirements of Teva group and there was no external sale to third parties<br />
Watson Pharma | 30/11/2022 | By Sudeep Soparkar | 768
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy